Treatment of inflammatory bowel disease: a comprehensive review

Z Cai, S Wang, J Li - Frontiers in medicine, 2021 - frontiersin.org
Inflammatory bowel disease (IBD), as a global disease, has attracted much research
interest. Constant research has led to a better understanding of the disease condition and …

Crohn disease: epidemiology, diagnosis, and management

JD Feuerstein, AS Cheifetz - Mayo Clinic Proceedings, 2017 - Elsevier
Crohn disease is a chronic idiopathic inflammatory bowel disease condition characterized
by skip lesions and transmural inflammation that can affect the entire gastrointestinal tract …

Resolution of chronic inflammatory disease: universal and tissue-specific concepts

G Schett, MF Neurath - Nature communications, 2018 - nature.com
Inflammation and its resolution is under-studied in medicine despite being essential for
understanding the development of chronic inflammatory disease. In this review article, we …

Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: a systematic review and meta-analysis

S Singh, A Facciorusso, AG Singh, NV Casteele… - PLoS …, 2018 - journals.plos.org
Objectives We sought to evaluate the association between obesity and response to anti-
tumor necrosis factor-α (TNF) agents, through a systematic review and meta-analysis …

[HTML][HTML] Immune checkpoint Inhibitor–Induced diarrhea and Colitis: Incidence and Management. A systematic review and Meta-analysis

DL Nielsen, CB Juhl, IM Chen, L Kellermann… - Cancer Treatment …, 2022 - Elsevier
Abstract Background Immune checkpoint inhibitors (ICIs) have improved cancer outcomes.
However, immune-related adverse effects are common. The aim was to investigate the …

Ulcerative colitis: epidemiology, diagnosis, and management

JD Feuerstein, AS Cheifetz - Mayo Clinic Proceedings, 2014 - Elsevier
Ulcerative colitis is a chronic idiopathic inflammatory bowel disease characterized by
continuous mucosal inflammation that starts in the rectum and extends proximally. Typical …

Systematic review and network meta‐analysis: first‐and second‐line biologic therapies for moderate‐severe Crohn's disease

S Singh, M Fumery, WJ Sandborn… - Alimentary …, 2018 - Wiley Online Library
Background There are limited data to inform positioning of agents for treating moderate‐
severe Crohn's disease (CD). Aim We assessed comparative efficacy and safety of first‐line …

Primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammatory bowel diseases: a …

S Singh, J George, BS Boland… - Journal of Crohn's …, 2018 - academic.oup.com
Abstract Background and Aims We sought to analyze whether response to a second-line
biologic varies depending on the reason for discontinuation of the primary anti-TNF agent …

[HTML][HTML] Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis

OH Nielsen, JM Gubatan, CB Juhl, SE Streett… - Clinical …, 2022 - Elsevier
Background & Aims Biologics are used routinely in pregnant women with inflammatory
bowel disease (IBD), but large-scale data reporting adverse pregnancy outcomes among …

[HTML][HTML] Histamine and T helper cytokine–driven epithelial barrier dysfunction in allergic rhinitis

B Steelant, SF Seys, L Van Gerven… - Journal of Allergy and …, 2018 - Elsevier
Background Allergic rhinitis (AR) is characterized by mucosal inflammation, driven by
activated immune cells. Mast cells and TH 2 cells might decrease epithelial barrier integrity …